½ÃÀ庸°í¼­
»óǰÄÚµå
1812607

¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á µµ±¸

Cell and Gene Therapy Tools

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Strategic Directions International, Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 127 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀÌ Á¶»ç º¸°í¼­ "¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á µµ±¸"´Â ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¿¬±¸°³¹ß¿¡ »ç¿ëµÇ´Â µµ±¸¿Í Á¦Ç° ¼¼°è ½ÃÀåÀ» Æ÷°ýÀûÀ¸·Î ºÐ¼®ÇÕ´Ï´Ù. º» º¸°í¼­´Â ÀÏ¹Ý ±â¼ú, À¯ÀüÀÚ Ä¡·á µµ±¸, µµÀÔ ¹× À̽Ä, ¼¼Æ÷ ³óÃà, ¼¼Æ÷ Áõ½Ä ¹èÁö, ¹ÙÀÌ¿À¸®¾×ÅÍ, µ¿°áº¸Á¸ µî 7°¡Áö ÁÖ¿ä Ä«Å×°í¸®¿¡ ´ëÇØ ½ÃÀå ±Ô¸ð, ¼ºÀå ¿ªÇÐ, ±â¼ú ¹ßÀü ÇöȲÀ» Á¶»çÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¹üÁÖ´Â Ãʱ⠴ܰèÀÇ ¿¬±¸ºÎÅÍ GMP¸¦ ÁؼöÇÏ´Â ÀÓ»ó °³¹ß±îÁö ¸ðµç ¿öÅ©Ç÷ο쿡 °ÉÃÄ ÀÖ½À´Ï´Ù.

À̹ø Á¶»ç´Â ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·áÀÇ ¹Ì·¡¸¦ Çü¼ºÇÏ´Â µ¥ ÀÖ¾î »ý¹°ÇÐÀû ½Ã½ºÅÛ, À¯ÀüÀÚ ÆíÁý ±â¼ú(CRISPR µî), ÷´Ü ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì Ç÷§ÆûÀÌ Áß¿äÇÑ ¿ªÇÒÀ» ÇÒ °ÍÀ̶ó´Â Á¡¿¡ ÁÖ¸ñÇϰí ÀÖ½À´Ï´Ù. Á¦Ç° À¯Çü, ÃÖÁ¾ ½ÃÀå, ºÎ¹®, ±â´É, Áö¿ª, ¿ëµµº°·Î ½ÃÀåÀ» ¼¼ºÐÈ­Çϰí, º¥´õÀÇ ½ÃÀå Á¡À¯À² µ¥ÀÌÅ͸¦ ÅëÇÑ °æÀï ºÐ¼®µµ ¼ö·ÏÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå ¿ªÇÐ Çü¼º¿¡ ÀÖ¾î À¯Åë¾÷ü, ´ë¸®Á¡, Á¦3ÀÚ ¼­ºñ½º Á¦°ø¾÷üÀÇ ¿ªÇÒ»Ó¸¸ ¾Æ´Ï¶ó ÇÕº´°ú ÀμöÇÕº´ÀÇ ¿µÇâ¿¡ ´ëÇØ¼­µµ ÁÖ¸ñÇϰí ÀÖ½À´Ï´Ù.

º» º¸°í¼­´Â ±¤¹üÀ§ÇÑ 1Â÷ ¹× 2Â÷ Á¶»ç¸¦ ¹ÙÅÁÀ¸·Î ¼¼Æ÷ Ä¡·á ¹× À¯ÀüÀÚ Ä¡·á °³¹ßÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ±â¼ú¿¡ ÃÊÁ¡À» ¸ÂÃß¾î ºÐ¼® ±â±â ¾÷°è ÀÌÇØ°ü°èÀڵ鿡°Ô ½Ç¿ëÀûÀÎ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. ¸ðµç ½ÃÀå ¿¹ÃøÀº ½ÇÁ¦ ±¸¸Å »óȲÀ» ¹Ý¿µÇÑ ÃÖÁ¾»ç¿ëÀÚ °¡°ÝÀ¸·Î Á¦½ÃÇÕ´Ï´Ù.

¸ñÂ÷

¼Ò°³

¹è°æ

  • ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¼Ò°³
  • ±âȸ¿Í °úÁ¦
  • Áö¿ª µ¿Çâ
  • ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

½ÃÀå ¼ö¿ä

  • ½ÃÀå Àüü
  • ÀϹÝÀûÀÎ ±â¼ú
  • À¯ÀüÀÚ Ä¡·á Åø
  • ¼¼Æ÷ Áõ½Ä - ¹èÁö
  • ¼¼Æ÷ ³óÃà - ¹ÙÀÌ¿À¸®¾×ÅÍ
  • º¤ÅÍ °³¹ß
  • ¼¼Æ÷ ³óÃà
  • µ¿°áº¸Á¸

ºÎ·Ï

  • ÃÖ±ÙÀÇ SDi º¸°í¼­¿Í ÇâÈÄ SDi º¸°í¼­
KSM

The "Cell and Gene Therapy Tools & Products" report provides a comprehensive analysis of the global market for tools and products used in cell and gene therapy (C & GT) research and development. It examines market size, growth dynamics, and technological advancements across seven major categories of laboratory instrumentation and consumables: general techniques, gene therapy tools, transduction & transfection, cell enrichment, cell expansion media, bioreactors, and cryopreservation. These categories span the full workflow from early-stage research to GMP-compliant clinical development.

The study highlights the critical role of biological systems, gene editing technologies (e.g., CRISPR), and advanced bioprocessing platforms in shaping the future of C & GT. It offers segmented market insights by product type, end market, sector, function, region, and application, and includes competitive analysis with vendor market share data. Special attention is given to the impact of mergers and acquisitions, as well as the role of distributors, agents, and third-party service providers in shaping market dynamics.

Based on extensive primary and secondary research, this report delivers actionable intelligence for stakeholders in the analytical instrument industry, with a focus on technologies enabling the development of cell and gene therapies. All market estimates are presented at end-user prices, reflecting real-world purchasing conditions.

Table of Contents

Introduction

  • About This Report
  • Segmentations
  • Executive Summary

Background

  • Introduction to Cell and Gene Therapy
  • Opportunities & Challenges
  • Regional Trends
  • Recent Market Developments

Market Demand

  • Overall Market
  • General Techniques
  • Gene Therapy Tools
  • Cell Expansion - Media
  • Cell Enrichment - Bioreactors
  • Vector Development
  • Cell Enrichment
  • Cryopreservation

Appendix

  • Recent & Upcoming SDi Reports
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦